RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 16:48:54 GMT 2025` Edited by `admin` on `Tue Apr 01 16:48:54 GMT 2025`
Protein Type	ENZYME
Protein Sub Type	TYROSINE KINASE
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	RSO83C9PIA
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3

Common Name

English

HER3

Preferred Name

English

PROTO-ONCOGENE-LIKE PROTEIN C-ERBB-3

Common Name

English

ERBB3

Common Name

English

TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER3

Common Name

English

Code System Code Type Description

PHAROS

P21860

Created by admin on Tue Apr 01 16:48:54 GMT 2025 , Edited by admin on Tue Apr 01 16:48:54 GMT 2025

PRIMARY

UNIPROT

P21860

Created by admin on Tue Apr 01 16:48:54 GMT 2025 , Edited by admin on Tue Apr 01 16:48:54 GMT 2025

PRIMARY

FDA UNII

RSO83C9PIA

Created by admin on Tue Apr 01 16:48:54 GMT 2025 , Edited by admin on Tue Apr 01 16:48:54 GMT 2025

PRIMARY

From	To
1_10	1_37
1_137	1_164
1_167	1_175
1_171	1_183
1_191	1_199
1_195	1_207
1_208	1_216
1_212	1_224
1_227	1_236
1_240	1_267
1_271	1_282
1_286	1_301
1_304	1_308
1_481	1_490
1_485	1_498
1_501	1_510
1_514	1_530
1_533	1_546
1_537	1_554
1_557	1_566
1_570	1_591
1_594	1_602
1_598	1_610

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_107
N	1_231
N	1_334
N	1_389
N	1_395
N	1_418
N	1_450
N	1_503
N	1_547
N	1_597

Related Record Type Details


					HZZ2SGC2TW

Nezutatug

LIGAND->TARGET

Amount:


					93F274N35Z

REGN-1400

INHIBITOR -> TARGET


					1N3L70MDFX

INHIBITOR -> TARGET


					00X6I56YXR

CDX-3379

INHIBITOR -> TARGET

Amount:

3499328002

SAPITINIB

INHIBITOR -> TARGET


					QZA4R4JG2Z

Ruzaltatug Rezetecan

LIGAND->TARGET

Amount:


					5F1CN52GFM

INHIBITOR -> TARGET


					M9SE4M9U1V

INHIBITOR -> TARGET

Comments:

ISU104 completely suppressed Heregulin HRG-induced phosphorylation

Amount:


					S8YH2C9NLA

INHIBITOR -> TARGET

Amount:


					GS38RAB375

LIGAND->TARGET

Amount:


					AE72RB1W1X

INHIBITOR -> TARGET

Comments:

IgG1 bispecific antibody with enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) activity targeting HER2 and HER3 receptors.

Amount:


					UC2FX6YY3P

Izalontamab Brengitecan

INHIBITOR -> TARGET

Amount:


					86780VJI1Q

INHIBITOR -> TARGET

Amount:


					3XPI7EG4W8

Patritumab Deruxtecan

LIGAND->TARGET

Amount:


					XLR461MD3M

INHIBITOR -> TARGET

Interaction Type:

BINDING

Amount:


					Y6M3205516

INHIBITOR -> TARGET


					8PMF8YQX2T

INHIBITOR -> TARGET

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_667] [1_963]				DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL